Pharmacological reactivity of dystrophic muscle.
D000814:Aniline Compounds / Q000633:toxicity*; D000818:Animals; D003964:Diaphragm; D005703:Gallamine Triethiodide / Q000494:pharmacology; D066298:In Vitro Techniques; D051379:Mice; D009136:Muscular Dystrophies; D009388:Neostigmine / Q000494:pharmacology*; D009469:Neuromuscular Junction / Q000187:drug effects*; D010791:Phrenic Nerve; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats; D013390:Succinylcholine / Q000494:pharmacology*; D014403:Tubocurarine / Q000494:pharmacology*
D000814:Aniline Compounds; D009388:Neostigmine; D010830:Physostigmine; D013390:Succinylcholine; D005703:Gallamine Triethiodide; D014403:Tubocurarine